346 related articles for article (PubMed ID: 15387897)
1. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
Wilkinson-Berka JL
Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature.
Fletcher EL; Phipps JA; Ward MM; Vessey KA; Wilkinson-Berka JL
Prog Retin Eye Res; 2010 Jul; 29(4):284-311. PubMed ID: 20380890
[TBL] [Abstract][Full Text] [Related]
3. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin and diabetic retinopathy.
Wilkinson-Berka JL
Int J Biochem Cell Biol; 2006; 38(5-6):752-65. PubMed ID: 16165393
[TBL] [Abstract][Full Text] [Related]
5. The Renin-Angiotensin system and vascular disease in diabetes.
Deinum J; Chaturvedi N
Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin-aldosterone system and the eye in diabetes.
Strain WD; Chaturvedi N
J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):243-6. PubMed ID: 12584667
[TBL] [Abstract][Full Text] [Related]
7. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
9. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
Clermont A; Bursell SE; Feener EP
J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
[TBL] [Abstract][Full Text] [Related]
10. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.
Wilkinson-Berka JL; Fletcher EL
Curr Pharm Des; 2004; 10(27):3313-30. PubMed ID: 15544518
[TBL] [Abstract][Full Text] [Related]
12. Prospects for angiotensin receptor blockers in diabetic retinopathy.
Sjølie AK
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
[TBL] [Abstract][Full Text] [Related]
13. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
14. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
Sjølie AK; Chaturvedi N
J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
Wilkinson-Berka JL; Rana I; Armani R; Agrotis A
Clin Sci (Lond); 2013 May; 124(10):597-615. PubMed ID: 23379642
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin system and diabetic retinopathy.
Kohner EM
Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187
[TBL] [Abstract][Full Text] [Related]
17. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Zhang JZ; Xi X; Gao L; Kern TS
Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
[TBL] [Abstract][Full Text] [Related]
18. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
[TBL] [Abstract][Full Text] [Related]
19. Novel role of erythropoietin in proliferative diabetic retinopathy.
Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
[TBL] [Abstract][Full Text] [Related]
20. Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?
Khakoo AY; Sidman RL; Pasqualini R; Arap W
Cancer Res; 2008 Nov; 68(22):9112-5. PubMed ID: 19010879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
